Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > 01302 LIFETECH SCI > Key Indicators
01302 LIFETECH SCI
2.440
-0.040-1.61%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Per Share IndicaTor
Operating Cash Flow Per Share
48.55% 0.1291 92.78% 0.0518 22.34% 0.0869 -9.81% 0.0269
Cash Flow Per Share
-77.68% 0.0385 -1671.73% -0.0998 1345.85% 0.1725 130.5% 0.0063
Operating Income Per Share
48.2% 0.2444 73.37% 0.1198 -4.58% 0.1649 -14.76% 0.0691
Net Asset Per Share
10.06% 0.6614 107.58% 0.6633 101.86% 0.6009 -10.69% 0.3196
Basic Earning Per Share
40% 0.0832 124.32% 0.0565 71.66% 0.0594 5.47% 0.0252
Diluted  Earning Per Share
34.45% 0.0783 114.78% 0.0541 68.23% 0.0582 5.47% 0.0252
Profitability
Gross Profit Ratio
1.12% 80.785% 2.08% 81.180% -0.08% 79.892% -3.29% 79.524%
Operating Profit Ratio
-13.73% 35.527% 12.51% 49.363% 45.92% 41.178% 18.88% 43.875%
Net Profit Ratio
-5% 30.622% 23.48% 43.512% 69.55% 32.235% 17.51% 35.238%
Earning Before Tax Ratio
-4.75% 35.979% 23.07% 50.271% 47.92% 37.774% 15.86% 40.847%
ROE
-3.02% 12.245% 3.44% 8.398% 18.41% 12.627% 14.72% 8.119%
ROA
3.28% 9.662% 26.92% 6.795% 20.97% 9.355% 1.39% 5.354%
Yield Quality
Operating Profit To Total Profits
-9.42% 98.742% -8.58% 98.193% -1.35% 109.012% 2.61% 107.413%
Tax To Total Profits
1.53% 14.889% -2.09% 13.446% -42.61% 14.665% -8.08% 13.733%
Operating Cash To Total Revenue
0.23% 52.830% 11.19% 43.228% 28.2% 52.706% 5.8% 38.878%
Capital Structure
Debt Assets Ratio
1.76% 20.530% -48.61% 16.851% -41.44% 20.174% 8.44% 32.789%
Equity Multipler
0.72% 1.2717 -19% 1.2118 -17.93% 1.2626 4.09% 1.496
Debt Equity Ratio
2.22% 25.833% -58.46% 20.266% -51.92% 25.273% 12.56% 48.786%
Current Assets To tatal Assets
10.36% 57.702% 55.7% 51.807% 52.96% 52.287% -1.6% 33.275%
Non Current Assets To Total Assets
-11.35% 42.298% -27.77% 48.193% -27.51% 47.713% 0.82% 66.725%
Current Liabilities To tatal Liabilities
-10.97% 73.730% 3.62% 79.446% 48.18% 82.811% 48.41% 76.667%
Non Current Liabilities To Total Liabilities
52.83% 26.270% -11.91% 20.554% -61.03% 17.189% -51.73% 23.333%
Solvency
Current Ratio
21.8% 3.8121 192.36% 3.8698 76.29% 3.1297 -38.86% 1.3236
Quick Ratio
21.04% 3.5438 220.28% 3.6167 97.18% 2.9279 -38.92% 1.1292
Operating Profit To Current Liabilities
27.31% 0.6822 117.83% 0.5493 -3.13% 0.5358 -32.26% 0.2522
Operrating Cash Flow To Current Liabilities
47.91% 1.0144 115.28% 0.4811 -14.9% 0.6858 -39.72% 0.2235
Share Equity Without Minority Interest To Total Liabilities
-2.44% 3.8304 140.21% 4.8971 108.08% 3.926 -11.41% 2.0387
Operating Cash Flow To Total Liabilities
31.69% 0.7479 123.08% 0.3822 26.1% 0.568 -10.54% 0.1713
Operating Profit To Total Liabilities
13.35% 0.503 125.73% 0.4364 43.53% 0.4437 0.53% 0.1933
Operating Capacity
Inventory Turnover(T)
17.38% 1.573 47.69% 0.8536 -14.23% 1.3401 -11.53% 0.578
Current Assets Turnover(T)
-8.75% 0.5545 -32.75% 0.2946 -45.58% 0.6077 -11.71% 0.438
Fixed Assets Turnover(T)
3.64% 1.7552 39% 1.0119 -8.44% 1.6936 -17.1% 0.728
Total Assets Turnover(T)
9.94% 0.3057 3.8% 0.1533 -30.55% 0.2781 -16.25% 0.1477
Growth Ability
Operating Revenue GR 3Y
39.71% 78.132% 88.14% 89.262% -37.37% 55.925% -48.36% 47.444%
Gross Income GR 3Y
42.09% 76.060% 85.25% 85.731% -42.52% 53.529% -53.26% 46.279%
Operating Profit GR 3Y
212.44% 114.570% 490.31% 146.592% -50.47% 36.669% -72.57% 24.833%
EBT GR 3Y
363.75% 113.406% 891.32% 144.718% 379.08% 24.454% -78.32% 14.598%
Net Profit GR 3Y
484.28% 150.234% 2254.15% 201.363% 300.07% 25.713% -88.31% 8.554%
Net Profit Attributable To The Parent Company GR 3Y
407.79% 158.861% 1681.16% 207.615% 373.92% 31.285% -84.04% 11.656%
Total Assets GR 3Y
-5.99% 122.314% 318.27% 133.400% 291.24% 130.107% -66.49% 31.893%
Share Equity Without Minority Interest GR 3Y
-3.36% 115.792% 411.02% 125.364% 265.41% 119.819% -94.36% 24.532%
Equity GR 3Y
-2.81% 117.471% 409.19% 126.418% 261.41% 120.873% -94.24% 24.827%
Total Liabilities GR 3Y
-18.45% 143.286% 256.24% 175.287% 434.16% 175.714% 338.24% 49.205%
Basic Earning Per Share GR 3Y
422.32% 160.263% 1215.84% 197.640% 318.99% 30.683% -73.63% 15.020%
Net Assets Per Share GR 3Y
-3.39% 102.101% 354.13% 111.168% 222.07% 105.685% -93.8% 24.480%
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Xianjian Technology Co., Ltd. is a company mainly engaged in manufacturing and marketing minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through three business divisions. The congenital Heart Disease Division is engaged in the research, development, manufacture and trading of equipment related to the treatment of congenital and structural heart disease. The peripheral vascular disease business division is engaged in the research, development, manufacture and trading of equipment related to the treatment of peripheral vascular diseases. The surgical vascular repair business division is engaged in the research, development, manufacture and trading of equipment related to surgical vascular repair.
CEO: Yuehui Xie
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top